Do individuals with inflammatory arthritis receive minimally adequate treatment for incident depression and anxiety: A population-based study
Authors' conclusion
A substantial proportion of individuals with IA were not receiving adequate mental health treatment for depression and anxiety, a finding similar for IA-free controls.
Study context
- Population
- Individuals with and without inflammatory arthritis with incident depression and/or anxiety, British Columbia, CanadaIA: 6,951 depression
- Exposure
- Individuals with inflammatory arthritis vs IA-free controls
- Outcome
- Minimally adequate treatment: antidepressant prescriptions filled with ≥ 84 days' supply (pharmacotherapy); ≥ 4 counselling/psychotherapy services (psychological treatment)
Methodological detailslinked administrative health databases, multivariable logistic regression
- Linked administrative health databases
- Multivariable logistic regression
Main finding
As reported in the abstract
Minimally adequate treatment for depression
IA
50.5%
IA vs IA-free controlsAdjusted odds ratio (95% CI)
Pharmacotherapy
1.10(1.00–1.21)
Psychological treatment
1.07(0.94–1.21)
Observational data: associations, not effects.
Further findings
≥ 1 benzodiazepine dispensed (anxiety)
P < 0.001
≥ 1 tricyclic antidepressant prescription (anxiety)
P < 0.001
Average days' supply of benzodiazepines (anxiety)
P = 0.003
Minimally adequate treatment for anxiety
- Results were similar regarding anxiety treatment
Original publication
Do individuals with inflammatory arthritis receive minimally adequate treatment for incident depression and anxiety: A population-based study. Arthritis Res Ther. Published 21 January 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →